Opinion|Videos|July 15, 2024
Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs
Author(s)Vivian Shi, MD, FAAD
An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How does current treatment of HS correlate to the Hurley staging system?
- What are the unmet needs for the treatment of HS?
Advertisement
Related to this article
Remibrutinib (Rhapsido; Novartis) is the only treatment with approved uses in both chronic spontaneous urticaria and symptomatic dermographism.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
Navigating GLP-1 Access & Prior Authorizations: Amanda Velazquez, MD
5